Concepedia

Clément N. David

CN

Statistics

Publications

14

Citations

1.3K

H-Index

13

Active since

2012

Affiliations

Nanostring Technologies (United States)(Current)

University of California, Riverside

University of Massachusetts Chan Medical School

University of North Carolina at Chapel Hill

University of California, Irvine

Clément N. David is an author at Nanostring Technologies (United States) specializing in immunology, life sciences, and neuroscience.

ORCID

Publications per year

2012–2023

14

Publications

14

NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes

Leslie Freeman, Haitao Guo, Clément N. David et al. · The Journal of Experimental Medicine · 2017 · 403 citations · Full text

, , +17

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins et al. · JCI Insight · 2018 · 252 citations · Full text

, , +17

GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii

Clément N. David, Elma S. Frias, Jenny I. Szu et al. · PLoS Pathogens · 2016 · 171 citations · Full text

, , +17

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 151 citations

, , +16

Chitinase Dependent Control of Protozoan Cyst Burden in the Brain

J. Philip Nance, Kevin M. Vannella, Danielle Worth et al. · PLoS Pathogens · 2012 · 68 citations · Full text

, , +17

1–5 of 14